Institut Català de la Salut
[Samarkanova D] Banc de Sang i Teixits, 08005 Barcelona, Spain. Grup de Recerca en Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Cox S, Hernandez D] Anthony Nolan Research Institute, Royal Free Hospital, London, UK. Barcelona Tissue Bank, Banc de Sang i Teixits, Barcelona, Spain. [Rodriguez L] Banc de Sang i Teixits, 08005 Barcelona, Spain. [Pérez ML] Banc de Sang i Teixits, 08005 Barcelona, Spain. Barcelona Tissue Bank, Banc de Sang i Teixits, Barcelona, Spain. Regenerative Medicine and Tissue Bioengineering Research Group (SGR 1113), Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain. [Madrigal A] Banc de Sang i Teixits, 08005 Barcelona, Spain. Anthony Nolan Research Institute, Royal Free Hospital, London, UK. UCL Cancer Institute, Royal Free Campus, London, UK. [Querol S] Banc de Sang i Teixits, 08005 Barcelona, Spain. Grup de Recerca en Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2022-03-25T07:23:15Z
2022-03-25T07:23:15Z
2021-07-02
Immunologia; Investigació mèdica
Inmunología; Investigación médica
Immunology; Medical research
Diseases and injuries that compromise the ocular surface cause considerable patient distress and have long term consequences for their quality of life. Treatment modalities that can address the delicate balance of tissue regeneration, inflammation and maintenance of corneal transparency are therefore needed. We have recently formulated two novel eye drops from placental tissues: cord blood platelet lysate (CBED) and amniotic membrane extract eye drops (AMED), which can be used to treat severe ocular disorders. Here we characterise these two preparations by measuring: (a) growth factors (GF) and cytokines composition, (b) promotion of human corneal epithelial cell (HCEC) growth and (c) effects on immune cells in a lymphocyte culture assay. Finally, their bioavailability was assayed in an ex vivo porcine corneal model. We show that both preparations contain GF and cytokines that were able to promote the in vitro growth of HCEC and support repair in an in vitro scratch test. When assessed in a lymphocyte culture, both favoured immune suppression reducing the cellular expression of NKG2D and CD107a as well as the production of interferon gamma (IFN-γ) in natural killer, NKT and T cells. Regarding bioavailability, CBED active molecules were found mainly in the pre-corneal fraction with some penetration into the corneal fraction, in an ex vivo model. In summary, both placental-derived allogeneic preparations, CBED and AMED, display regenerative and immunomodulatory capabilities. These results will help define mechanisms of action and the best indications and doses of each product for use in a particular patient and support the development of off-the-shelf therapies for ocular surface pathologies in which wound healing defects and inflammatory events are contributing factors.
This work was funded by BST intern grant (Ref I. 2017.036), and Anthony Nolan core funding.
Article
Versió publicada
Anglès
Còrnia - Malalties - Tractament; Farmacologia ocular; Sang fetal - Ús terapèutic - Eficàcia; DISEASES::Eye Diseases::Corneal Diseases; Other subheadings::Other subheadings::Other subheadings::/drug therapy; CHEMICALS AND DRUGS::Pharmaceutical Preparations::Solutions::Pharmaceutical Solutions::Ophthalmic Solutions; ANATOMY::Fluids and Secretions::Body Fluids::Blood::Fetal Blood; ENFERMEDADES::oftalmopatías::enfermedades de la córnea; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; COMPUESTOS QUÍMICOS Y DROGAS::preparados farmacéuticos::soluciones::soluciones farmacéuticas::soluciones oftálmicas; ANATOMÍA::líquidos y secreciones::líquidos corporales::sangre::sangre fetal
Nature Research
Scientific Reports;11
https://doi.org/10.1038/s41598-021-93150-7
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]